Brita B. Jensen

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Cervical lymph node metastases from unknown primary tumours

Cai Grau, Lars Vendelbo Johansen, John Jakobsen et al. · Radiotherapy and Oncology · 2000 · 341 citations

Medicine, Oncology, Surgery +14

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer

Mogens K. Boisen, Julia S. Johansen, Christian Dehlendorff et al. · Annals of Oncology · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer

Bent Ejlertsen, Henning T. Mouridsen, Maj‐Britt Jensen et al. · European Journal of Cancer · 2007 · 63 citations

Medicine, Oncology, Pharmacology +6